Using Continuous Glucose Monitoring Data and Detrended Fluctuation Analysis to Determine Patient Condition
Open Access
- 30 June 2015
- journal article
- review article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 9 (6) , 1327-1335
Abstract
Patients admitted to critical care often experience dysglycemia and high levels of insulin resistance, various intensive insulin therapy protocols and methods have attempted to safely normalize blood glucose (BG) levels. Continuous glucose monitoring (CGM) devices allow glycemic dynamics to be captured much more frequently (every 2-5 minutes) than traditional measures of blood glucose and have begun to be used in critical care patients and neonates to help monitor dysglycemia. In an attempt to obtain a better insight relating biomedical signals and patient status, some researchers have turned toward advanced time series analysis methods. In particular, Detrended Fluctuation Analysis (DFA) has been a topic of many recent studies in to glycemic dynamics. DFA investigates the “complexity” of a signal, how one point in time changes relative to its neighboring points, and DFA has been applied to signals like the inter-beat-interval of human heartbeat to differentiate healthy and pathological conditions. Analyzing the glucose metabolic system with such signal processing tools as DFA has been enabled by the emergence of high quality CGM devices. However, there are several inconsistencies within the published work applying DFA to CGM signals. Therefore, this article presents a review and a “how-to” tutorial of DFA, and in particular its application to CGM signals to ensure the methods used to determine complexity are used correctly and so that any relationship between complexity and patient outcome is robust.Keywords
This publication has 54 references indexed in Scilit:
- Effect of an Intensive Glucose Management Protocol on the Mortality of Critically Ill Adult PatientsMayo Clinic Proceedings, 2004
- Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill PatientsMayo Clinic Proceedings, 2003
- Glucose Control and Mortality in Critically Ill PatientsJAMA, 2003
- Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*Critical Care Medicine, 2003
- Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Alterations in fuel metabolism in critical illness: hyperglycaemiaBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- Intensive Insulin Therapy in Critically Ill PatientsNew England Journal of Medicine, 2001
- Hyperglycemia and Infection: Which is the Chicken and Which is the Egg?Journal of Parenteral and Enteral Nutrition, 2001
- Stress-Induced HyperglycemiaCritical Care Clinics, 2001
- Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overviewThe Lancet, 2000